One British medical research institute revealed that the Oxford AstraZeneca vaccine uses a Trojan horse delivery system linked to an uptick in a severe neurological disorder called Guillain-Barre syndrome (GBS).
“Like many vaccines, the Oxford jab uses a weakened chimp adenovirus to deliver the coronavirus spike protein into the body, and scientists have speculated that a reaction to adenovirus may be responsible for the rise in cases,” the Telegraph reported. “Adenovirus usually causes the common cold, but scientists are starting to think it may also mimic human cells in a similar way to [the gastroenteritis bug] Campylobacter, confusing the immune system into attacking the body.”
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
The study is led by Professor Michael Lunn of the UCL Queen Square Institute of Neurology, so he emphasized,
“At the moment, we don’t know why a vaccine may cause these very small rises in GBS. It may be that a non-specific immune activation in susceptible individuals occurs, but if that were the case, similar risks might apply to all vaccine types.”
“It is, therefore, logical to suggest that the simian adenovirus vector, often used to develop vaccines, including AstraZeneca’s, may account for the increased risk,” he added.
“GBS is a rare condition which causes muscle numbness and pain, and can hinder movement, walking, swallowing and, sometimes, even breathing,” the report adds.
AstraZeneca shot isn’t approved in the US, but it isn’t the only C-19 shot that has been found to have serious side effects.
“The FDA said its analysis had determined that the risk of thrombosis with thrombocytopenia syndrome after the administration of the shot warrants limiting of the authorization,” CNBC reported.
“We recognize that the Janssen COVID-19 Vaccine still has a role in the current pandemic response in the United States and across the global community,” said Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research. “Our action reflects our updated analysis of the risk of TTS following administration of this vaccine and limits the use of the vaccine to certain individuals.”
Johnson and Johnson’s shots are limited to adults 18+.
One MIT study found that there is an increased risk of heart inflammation among 16-39 year-olds in Israel.
“COVID-19 vaccination was ‘significantly associated with a 25% jump in emergency medical services (EMS) for heart problems in 16-39 year-olds in Israel, whose vaccination rate is among the world’s highest, according to a peer-reviewed study by MIT researchers,” Just the News reported.
“While not establishing causal relationships, the findings raise concerns regarding vaccine-induced undetected severe cardiovascular side-effects and underscore the already established causal relationship between vaccines and myocarditis, a frequent cause of unexpected cardiac arrest in young individuals,” the study says.
In October 2021, some EU countries banned the use of Moderna shots due to the increased risk of heart inflammation among young persons.
Another study shared in April found that the Moderna shot can impair the long-term development and retention of C-19 fighting antibodies.
The complex study entitled “Anti-nucleocapsid antibodies following SARS-CoV-2 infection in the blinded phase of the mRNA-1273 Covid-19 vaccine efficacy clinical trial” presented that the vaccinated had impaired ability to produce specific kinds of C-19 relevant antibodies versus the unvaccinated but had natural immunity from prior infections.
“These data show that, among the participants with PCR-confirmed Covid-19 disease, anti-N Ab seropositivity [a particular kind of antibody] at a median of 53 days post-diagnosis occurred in 40% of the mRNA-1273 vaccine recipients vs. 93% of the placebo recipients,” the study states.
“While an increase in seroreversion cannot be ruled out, given the short time frame, the more likely explanation is a vaccine-induced reduction in seroconversion,” the authors state.
“We also know that in this country because of vaccines because of boosters and because of protection from prior disease, infection-induced immunity (natural immunity) that about 95% of people in this country have some level of protection,” she said.